Welcome to our dedicated page for Iperionx SEC filings (Ticker: IPX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IperionX Limited filings document foreign private issuer reports, operating updates, governance actions, and market disclosures for a Nasdaq and ASX-listed titanium technology company. Form 6-K exhibits include quarterly reports on titanium powder production and component manufacturing, shareholder letters, investor presentations, meeting materials, ASX correspondence, and notices of company secretary and registered-office changes.
The filings describe the company’s HAMR™ and HSPT™ technologies, Virginia Titanium Manufacturing Campus, Titan critical minerals project, U.S. Department of War grant programs, reimbursement mechanics, equipment procurement treatment, and customer-related manufacturing activity. Governance and ownership disclosures cover shareholder meeting results, equity incentive approvals, director and officer ownership changes, and communications between the company and ASX.
IperionX Limited filed a Form 6‑K with a detailed feasibility‑study Technical Report Summary for its Titan heavy mineral sands project in Tennessee. The study outlines measured and indicated mineral resources of 347.9 Mt at 2.1% total heavy minerals and proven and probable reserves of 117.0 Mt at 3.2% THM. The mine plan targets 14 years of production, starting at 3.5 Mt per year and ramping to 10.0 Mt per year, supplying a 400 tph then 1,200 tph processing circuit. Total development capital for both phases is about US$381 million, with average operating costs of US$13.31/t in Phase 1 and US$10.57/t in Phase 2. The feasibility case generates total EBITDA of US$2,804 million, an after‑tax NPV8 of US$813 million and an after‑tax IRR of 39.4%, with payback in roughly 3.6 years, while sensitivity analysis shows the project is most exposed to product prices and head grade.
IperionX Limited has completed a Definitive Feasibility Study (DFS) for its Titan Critical Minerals Project in Tennessee, outlining a large, long-life U.S. source of rare earths, titanium and zircon. The DFS forecasts an after-tax NPV8 of US$813 million, an after-tax IRR of 39.4% and an after-tax payback period of 3.6 years from a 14-year mine plan. Total development capital is estimated at US$381.3 million, split into Phase 1 capital of US$228.1 million and Phase 2 incremental capital of US$153.2 million. Over the mine life, Titan is expected to generate total EBITDA of about US$2.8 billion and after-tax free cash flow of about US$1.93 billion. The Ore Reserve stands at 117 million tons at 3.17% total heavy minerals, supporting production of heavy rare earth concentrate enriched in dysprosium, terbium and yttrium, plus ilmenite, rutile and zircon concentrates. The project benefits from U.S. Government IBAS funding, key permits already in place and established U.S. infrastructure, but still depends on securing project financing and timely permitting for full development.
IperionX Limited reported independent test results showing its Ti-6Al-4V titanium fasteners can match or exceed key strength benchmarks of high-strength Grade 8 steel fasteners while remaining significantly lighter. U.S. Army DEVCOM GVSC torque testing on 3/4-10 fasteners found IperionX parts reached a yield torque of 563 to 615 ft-lbf, compared with 480 to 502 ft-lbf for comparable Grade 8 steel fasteners.
Additional U.S. Army and Westmoreland Mechanical Testing & Research programs confirmed that IperionX fasteners achieved 135 to 137 ksi yield strength and 149 to 152 ksi ultimate tensile strength, above typical aerospace Grade 5 titanium benchmarks and at or above key Grade 8 steel benchmarks. The company highlights that titanium Ti-6Al-4V is typically 40% to 45% lighter than steel, positioning these fasteners for defense, aerospace, marine and industrial applications where high-strength performance, lower weight, corrosion resistance and a secure U.S. supply chain are important.
IperionX Limited has commissioned a 300-ton six-axis SACMI powder metallurgy press at its Titanium Manufacturing Campus in South Boston, Virginia, expanding its U.S. titanium component manufacturing capabilities. The new press increases compaction capacity and enables production of more complex titanium parts for defense, aerospace and industrial customers.
The press uses titanium powder from IperionX’s patented HAMR™ process and produces near-net-shape preforms that are finished through the company’s HSPT™ sintering and forging technology. This integrated pathway is designed to bypass traditional titanium sponge and ingot routes, aiming to lower waste, costs and lead times while supporting higher-volume, repeatable production.
IPERIONX Ltd President Toby Symonds purchased 3,000 American Depository Shares (ADS) in an open-market transaction at $30.63 per ADS on April 28, 2026, increasing his direct ADS holdings to 37,000 ADS.
Each ADS represents ten ordinary shares, which trade on the ASX, while the ADS trade on Nasdaq. As of this filing, he also directly owns 3,128,089 ordinary shares and holds sizeable option and performance-right positions over additional ordinary shares at exercise prices between A$4 and A$22.
IPERIONX Ltd Chief Financial Officer Marcela Rocha Castro reported new equity awards and updated holdings. On April 2, 2026, she received 52,258 Restricted Stock Units (RSUs) at A$0.00 per unit as part of her annual bonus. These RSUs are scheduled to vest in tranches, including 52,258 vesting in April 2029.
On the same date, she was also granted 127,993 options with an exercise price of A$11.00 per share, likewise described as part of her annual bonus. Each option gives the right to purchase one ordinary share.
After these awards, she directly holds 380,841 ordinary shares, 214,259 RSUs, and options over ordinary shares, including options linked to 216,672 underlying shares at an exercise price of A$5.00 expiring in 2029 and the new 127,993 options at A$11.00 exercisable from 2029 and expiring in 2030. Ordinary shares are traded on the Australian Stock Exchange.
IPERIONX Ltd director Lorraine M. Martin bought 4,755 American Depository Shares (ADS) in an open-market purchase. The ADS were acquired at an average price of $31.4647 per ADS, and each ADS is equivalent to ten Ordinary Shares, or 47,550 Ordinary Shares in total.
After this transaction, Martin directly holds 4,755 ADS, 1,177,138 Ordinary Shares traded on the ASX, and 90,216 Restricted Stock Units (RSUs). According to the filing, 76,054 RSUs vest in December 2026 and 14,162 RSUs vest in December 2027, reflecting a sizable ongoing equity stake tied to future performance and service.
IPERIONX Ltd Chief Executive Officer Anastasios Arima reported an open-market purchase of 110,000 Ordinary Shares on April 28, 2026 at an average price of $4.4875 per share. Following this transaction, he directly holds 12,316,782 Ordinary Shares.
He also reports various equity incentives, including options over 639,205 Ordinary Shares at A$22 and 564,759 Ordinary Shares at A$18, plus multiple performance rights series and 128,000 American Depository Shares, each ADS being exchangeable into ten Ordinary Shares.
IPERIONX Ltd Executive Chairman Todd Hannigan reported significant open-market share purchases. On April 28, 2026, he bought 220,000 Ordinary Shares at an average price of $4.4819 per share, followed by another purchase of 260,000 Ordinary Shares at $4.1991 per share on April 29, 2026.
After these trades, he directly holds 26,108,334 Ordinary Shares, along with 454,464 Restricted Stock Units, 500,000 American Depository Shares, and several option and performance rights awards over additional Ordinary Shares. One ADS is exchangeable for 10 Ordinary Shares, highlighting a substantial overall equity exposure.